Chronic Administration of Quercetin Induces Biomechanical and Pharmacological Remodeling in the Rat Coronary Arteries
Authors:
- A. Monori-KissAMA. Monori-Kiss
- F. KissFKF. Kiss
- J. M. RestifoJRJ. M. Restifo
- E. MonosEME. Monos
- G. L. NadasyGNG. L. Nadasy
- 15 August 2017
- journal article
- Published by Institute of Physiology of the Czech Academy of Sciences in Physiological Research
- Vol. 66 (4) , 591-599
Abstract
Acute dilation brought about by the dietary flavonoid quercetin in coronary arterioles has been described earlier, but no information is available on its chronic effects. Male Wistar rats (body weight about 190 g) were divided to two groups: the quercetin-treated group (n=22) had quercetin supplementation of approximately 30 mg/kg/day, whereas the control group (n=20) had none. After eight weeks of treatment, intramural coronary arterioles with identical passive diameters (178±14 µm and 171±9 µm) were prepared and their biomechanics and pharmacological reactivities were tested using pressure arteriography ex vivo. The spontaneous tone of quercetin-treated arteries was higher (16.5±1.9 % vs. 12.9±0.9 %), which resulted in a reduced lumen size (144±9 μm vs. 167±12 μm), thicker vascular wall (22.6±1.8 μm vs. 17.4±1.6 μm) and decreased tangential wall stress (16.8±1.1 kPa vs. 20.5±1.6 kPa) in supplemented animals (in spontaneous tone at 50 mm Hg, p<0.01 in all these comparisons). Elevated basal NO release resulted in increased endothelial dilation in quercetin-treated animals, especially at higher intraluminal pressures (10.8±2.5 % vs. 5.7±1.3 % at 70 mm Hg, p<0.01). We found remodeling of the geometry of coronary arterioles to ensure higher dilatory reserve and nitrogen monoxide production, as well as lowered elastic stress of the vessel wall.Keywords
This publication has 32 references indexed in Scilit:
- Quercetin Inhibits Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats and Inhibits Angiotensin II-Induced H9C2 Cells Hypertrophy by Enhancing PPAR-γ Expression and Suppressing AP-1 ActivityPLOS ONE, 2013
- Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxideNutrition Research, 2012
- Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokersNutrition Research and Practice, 2011
- Effects of Quercetin on Gene and Protein Expression of NOX and NOS after Myocardial Ischemia and Reperfusion in RabbitCardiovascular Therapeutics, 2009
- Quercetin-Induced Induction of the NO/cGMP Pathway Depends on Ca2+-Activated K+Channel-Induced Hyperpolarization-Mediated Ca2+-Entry into Cultured Human Endothelial CellsPlanta Medica, 2005
- Effects of the Flavonoid Quercetin and its Methylated Metabolite Isorhamnetin in Isolated Arteries from Spontaneously Hypertensive RatsPlanta Medica, 2003
- Quercetin as a novel activator of L‐type Ca2+channels in rat tail artery smooth muscle cellsBritish Journal of Pharmacology, 2002
- Preparation of Intramural Small Coronary Artery and Arteriole Segments and Resistance Artery Networks from the Rat Heart for Microarteriography and for in Situ Perfusion Video MappingMicrovascular Research, 2001
- Dissociation of Phospholamban Regulation of Cardiac Sarcoplasmic Reticulum Ca2+ATPase by QuercetinJournal of Biological Chemistry, 1996
- Term "Vitamin P" Recommended to be DiscontinuedScience, 1950